Efficiency of E-learning and Role-playing for the Training of Nursing Home Caregivers in the Support of Agitation in Neurodegenerative Diseases

January 26, 2023 updated by: University Hospital, Tours

Efficacité du E-learning et du Jeu de rôle Pour la Formation Des Soignants Des EHPAD à l'Accompagnement de l'Agitation Dans Les Maladies neurodégénératives : Essai randomisé en Cluster

This study will investigate the effects of "I-Learn cognition and behaviour" training in the care in agitation in patients with neurodegenerative diseases. This training for caregivers, aims to reduce agitation and psycho-behavioral disorders of patients living in nursing home. In addition, amount of psychotropic drugs prescribed, as well as the number of hospitalizations during the study will be assessed.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

170

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Châteaugiron, France, 35000
        • EHPAD Résidence du Prévot
      • Liffré, France, 35340
        • Maison Saint Michel
      • Montlouis-sur-Loire, France, 37270
        • EHPAD La Bourdaisière
      • Pléchâtel, France, 35470
        • Résidence Père Brottier
      • Rochecorbon, France, 37210
        • EHPAD Le Clos Saint-Vincent
      • Tours, France, 37012
        • EHPAD Montconseil
      • Tours, France, 37100
        • EHPAD La Source

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Dependent elderly people with a neurodegenerative disease

Description

Inclusion Criteria:

  • Diagnosis of Major Neurocognitive Disorder according to DSM 5
  • With agitation and NPI agitation item score of 4 or more (frequency X severity)
  • Information and verification of the non-opposition of the patient and his guardian / curator if he is under legal protection.

Exclusion Criteria:

  • Patient under court protection
  • Inability to understand the French language
  • Patient whose state of health is not stabilised at the time of inclusion and/or in palliative care

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Experimental Group
The experimental group will be made up of patients from nursing homes whose carers have received I-Learn training.
Training of psycho-behavorial disorders care in neurodegenerative diseases: including a theoretical part in e-learning and a practical part
usual care
Control Group
The control group will consist of nursing homes patients whose caregivers have not received I-Learn training and will continue their usual care, regardless of the practices already implemented.
usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of agitation of patients in the nursing home
Time Frame: Baseline

Assessment of agitation using the Cohen-Mansfield Agitation Inventory (CMAI, 1989) by asking caregivers about the patients' behaviour.

The minimum value is 0 and the maximum value is 203. the higher the score, the more intense the agitation

Baseline
Measurement of agitation of patients in the nursing home
Time Frame: 3 months

Assessment of agitation using the Cohen-Mansfield Agitation Inventory (CMAI, 1989) by asking caregivers about the patients' behaviour.

The minimum value is 0 and the maximum value is 203. the higher the score, the more intense the agitation

3 months
Measurement of agitation of patients in the nursing home
Time Frame: 6 months

Assessment of agitation using the Cohen-Mansfield Agitation Inventory (CMAI, 1989) by asking caregivers about the patients' behaviour.

The minimum value is 0 and the maximum value is 203. the higher the score, the more intense the agitation

6 months
Measurement of agitation of patients in the nursing home
Time Frame: 9 months

Assessment of agitation using the Cohen-Mansfield Agitation Inventory (CMAI, 1989) by asking caregivers about the patients' behaviour.

The minimum value is 0 and the maximum value is 203. the higher the score, the more intense the agitation

9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency and severity of Psychobehavioural Symptoms associated with Dementia
Time Frame: Baseline, 3 months, 6 months and 9 months
Assessment using the Neuro Psychiatric Inventory, care team version (NPI-ES, 2000). 10 behavioural domains and 2 neurovegetative variables are considered. item score = frequency x severity frequency minimum = 1 and maximum = 4 severity minimum = 1 and maximum = 3 A score above 2 is pathological
Baseline, 3 months, 6 months and 9 months
Quality of life of patients
Time Frame: Baseline, 3 months, 6 months and 9 months
Assessment using the Quality of Life-Alzheimer's Disease (QOL-AD, 2009) 13 questions focus on the patient's quality of life. the patient's current quality of life in each domain is assessed by choosing one of the following four words: poor, fair, good, excellent.
Baseline, 3 months, 6 months and 9 months
Impact of I-Learn on psychotropic drug prescriptions
Time Frame: Baseline, 3 months, 6 months and 9 months
Changes in the prescriptions given to patients in terms of psychotropic drugs (addition or withdrawal of a neuroleptic, antidepressant, anxiolytic, etc.)
Baseline, 3 months, 6 months and 9 months
Impact of I-Learn on psychotropic drug prescriptions
Time Frame: Baseline, 3 months, 6 months and 9 months
Changes in the prescriptions given to patients in terms of dosage (increase/decrease of the daily dose)
Baseline, 3 months, 6 months and 9 months
Impact of I-Learn training on hospital admissions
Time Frame: 3 months, 6 months and 9 months
number of transfers to acute or emergency departments
3 months, 6 months and 9 months
Impact of I-Learn training on hospital admissions
Time Frame: 3 months, 6 months and 9 months
reasons for hospitalisation
3 months, 6 months and 9 months
Impact of Psychobehavioural Symptoms Associated with Dementia on the professional practice of health care teams
Time Frame: Baseline, 3 months, 6 months and 9 months
Assessment using the Neuro Psychiatric Inventory, care team version (NPI-ES, 2000) 10 behavioural domains and 2 neurovegetative variables are considered. item score = frequency x severity fequency minimum = 1 and maximum = 4 severity minimum = 1 and maximum = 3 A score above 2 is pathological
Baseline, 3 months, 6 months and 9 months
Caregiver burnout at work
Time Frame: Baseline, 6 months and 9 months

Assessment using the Maslach Burnout Inventory (MBI, 1986) 22 items For each item, the minimum value is 0 and the maximum value is 6 BURNOUT Questions 1.2.3.6.8.13.14.16.20 Degree of burn out Total below 17 = low Total between 18 and 29 = moderate Total above 30 = high

DEPERSONALISATION Questions 5.10.11.15.22 Degree of burn out Total below 5 = low Total between 6 and 11 = moderate Total above 12 = high

PERSONAL FULFILMENT Questions 4.7.9.12.17.18.19.21 Degree of burn out Total above 40 = low Total between 34 and 39 = moderate Total below 33 = high

Moderate or even high scores are a sign of latent burnout that is taking hold.

Baseline, 6 months and 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Céline LOURDEL, University Hospital, Tours

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 8, 2021

Primary Completion (Actual)

January 9, 2023

Study Completion (Actual)

January 9, 2023

Study Registration Dates

First Submitted

June 8, 2021

First Submitted That Met QC Criteria

June 17, 2021

First Posted (Actual)

June 23, 2021

Study Record Updates

Last Update Posted (Actual)

January 27, 2023

Last Update Submitted That Met QC Criteria

January 26, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • DR200087 (I-LEARN)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neuro-Degenerative Disease

Clinical Trials on I-LEARN training

3
Subscribe